Assessment of immunity to mycobacterial infection with luciferase reporter constructs

Infection and Immunity

Volumn 67, Issue 9, 1999, Pages 4586-4593

  Snewin, Valerie A ^a   Gares, Marie Pierre ^a   Ó Gaora, Peadar ^a   Hasan, Zahra ^a,b   Brown, Ivor N ^a   Young, Douglas B ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; LUCIFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL IMMUNITY; BIOLUMINESCENCE; COLONY FORMING UNIT; ENZYME ACTIVITY; FEMALE; IMMUNE STATUS; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

EID: 0032767290     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.9.4586-4593.1999     Document Type: Article

References (31)

1. Andrew, P. W., and I. S. Roberts. 1993. Construction of a bioluminescent mycobacterium and its use for assay of antimycobacterial agents. J. Clin. Microbiol. 31:2251-2254.
2. Arain, T. M., A. E. Resconi, M. J. Hickey, and K. Stover. 1996. Bioluminescence screening in vitro (Bio-siv) assays for high-volume antimycobacterial drug discovery. Antimicrob. Agents Chemother. 40:1536-1541.
3. Arain, T. M., A. E. Resconi, D. C. Singh, and K. Stover. 1996. Reporter gene technology to assess activity of antimycobacterial agents in macrophages. Antimicrob. Agents Chemother. 40:1542-1544.
4. Barry, M. A., W. C. Lai, and S. A. Johnston. 1995. Protection against mycoplasma infection using expression-library immunization. Nature 377: 632-635.
5. Carriere, C., P. Risks, O. Zimhony, J. Kriakov, S. Bardarov, J. Burns, J. Chan, and W. R. Jacobs, Jr. 1997. Conditionally replicating luciferase reporter phages: improved sensitivity for rapid detection and assessment of drug susceptibility of Mycobacterium tuberculosis. J. Clin. Microbiol. 35: 3232-3239.
6. Cole, S. T., R. Brosch, J. Parkhill, T. Garnier, C. Churcher, D. Harris, S. V. Gordon, K. Eiglmeier, S. Gas, C. E. Barry III, F. Tekaia, K. Badcock, D. Basham, O. Brown, T. Chillingworth, R. Connor, R Davies, K. Devlin, T. Feltwell, S. Gentles, N. Hamlin, S. Holroyd, T. Hornsby, K. Jagels, A. Krogh, J. McLean, S. Moule, L. Murphy, K. Oliver, J. Osborne, M. A. Quail, M.-A. Rajandream, J. Rogers, S. Rutter, K. Seeger, J. Skelton, R. Squares, S. Squares, J. E. Sulston, K. Taylor, S. Whitehead, and B. G. Barrell. 1988. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393:537-544.
7. Cooper, A., D. Dalton, T. Stewart, J. Griffin, D. Russell, and I. Orme. 1993. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J. Exp. Med. 178:2243-2247.
8. Dale, E. C., and D. W. Ow. 1990. Intra- and intermolecular site-specific recombination in plant cells mediated by bacteriophage P1 recombinase. Gene 91:79-85.
9. Davis, P. D. O. (ed.). 1998. Clinical tuberculosis, 2nd ed. Chapman & Hall Medical, London, England.
10. Flynn, J., K. L. Goldstein, K. Triebold, B. Koller, and B. Bloom. 1992. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. USA 89:12013-12017.
11. Frackman, S., M. Anhalt, and K. H. Nealson. 1990. Cloning, organization, and expression of the bioluminescence genes of Xenorhabdus luminescens. J. Bacteriol. 172:5767-5773.
12. Garbe, T. R., J. Barathi, S. Barnini, Y. Zhang, C. Abou-Zeid, D. Tang, R. Mukherjee, and D. B. Young. 1994. Transformation of mycobacterial species using hygromycin resistance as selectable marker. Microbiology 140:133-138.
13. Hickey, M. A., T. M. Arain, R. M. Shawar, D. J. Humble, M. H. Langhorne, J. N. Morgenroth, and C. K. Stover. 1996. Luciferase in vivo expression technology: use of recombinant mycobacterial reporter strains to evaluate antimycobacterial activity in mice. Antimicrob. Agents Chemother. 40:400-407.
14. Hill, P., and G. Stewart. 1994. Use of lux genes in applied biochemistry. J. Biolumin. Chemilumin. 9:211-215.
15. Huygen, K., J. Content, O. Denis, D. Montgomery, A. Yawman, R. Deck, C. DeWitt, I. Orme, S. Baldwin, C. D'Souza, A. Drowart, E. Lozes, P. Vandenbussche, J. Van Vooren, M. Liu, and J. Ulmer. 1996. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat. Med. 2:893-898.
16. Jacobs, W., Jr., R. G. Barletta, R. Udani, J. Chan, G. Kalkut, G. Sosne, T. Kieser, G. Sarkis, G. Hatfull, and B. Bloom. 1993. Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages. Science 260:819-822.
17. Janis, E., S. Kaufmann, R. Schwartz, and D. Pardoll. 1989. Activation of gamma delta T cells in the primary immune response to Mycobacterium tuberculosis. Science 244:713-716.
18. Meighen, E. 1991. Molecular biology of bacterial bioluminescence. Microbiol. Rev. 55:123-142.
19. Newport, M. J., C. M. Huxley, S. Huston, C. M. Hawrylowicz, B. A. Oostra, R. Williamson, and M. Levine. 1996. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 335:1941-1949.
20. Ó Gaora, P., S. Barnini, C. Hayward, E. Filley, G. Rook, D. Young, and J. Thole. 1997. Mycobacteria as immunogens: development of expression vectors for use in multiple mycobacterial species. Med. Princ. Pract. 6:91-96.
21. Orme, I. 1987. Aging and immunity to tuberculosis: increased susceptibility of old mice reflects a decreased capacity to generate mediator T lymphocytes. J. Immunol. 138:4414-4418.
22. Pablos-Mendez, A., M. Raviglione, A. Laszlo, N. Binkin, H. Rieder, F. Bustreo, D. Cohn, C. Lambregts-van Weezenbeek, S. Kim, P. Chaulet, and P. T. Nunn. 1998. Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N. Engl. J. Med. 338:1641-1649.
23. Pelicic, V., M. Jackson, J. M. Reyrat, W. R. Jacobs, Jr., B. Gicquel, and C. Guilhot. 1997. Efficient allelic exchange and transposon mutagenesis in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 94:10955-10960.
24. Raviglione, M., J. D. Snider, and K. A. Kochi. 1995. Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic. JAMA 273: 220-226.
25. Riska, P., W. R. Jacobs, Jr., B. Bloom, J. McKitrick, and J. Chan. 1997. Specific identification of Mycobacterium tuberculosis with the luciferase reporter mycobacteriophage: use of p-nitro-alpha-acetylamino-beta-hydroxy propiophenone. J. Clin. Microbiol. 35:3225-3231.
26. Rook, G., and B. Bloom. 1994. Mechanisms of pathogenesis in tuberculosis, p. 485-501. In B. Bloom (ed.), Tuberculosis: pathogenesis, protection and control. ASM Press, Washington, D.C.
27. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
28. Stover, C. K., V. F. de la Cruz, T. R. Fuerst, J. E. Burlein, L. A. Benson, L. T. Bennett, G. P. Bansal, J. F. Young, M. H. Lee, G. F. Hatfull, S. B. Snapper, R. G. Barletta, W. R. Jacobs, Jr., and B. R. Bloom. 1991 New use of BCG for recombinant vaccines. Nature 351:456-460.
29. Tascon, R. E., M. J. Colston, S. Ragno, E. Stavropoulos, D. Gregory, and D. B. Lowrie. 1996. Vaccination against tuberculosis by DNA injection. Nat. Med. 2:888-892.
30. Williams, A., V. A. Snewin, I. N. Brown, and D. B. Young. Unpublished data.
31. Zhang, Y., R. Lathigra, T. Garbe, D. Catty, and D. Young. 1991. Genetic analysis of superoxide dismutase, the 23 kilodalton antigen of Mycobacterium tuberculosis. Mol. Microbiol. 5:381-391.